Albuterol Sulfate Inhalation Solution
Product Images NDC 76204-010

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate Inhalation Solution (NDC 76204-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ritedose Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0 63 mg Carton Brick

Packaging label for Albuterol Sulfate Inhalation Solution 0.63 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label includes the product name, strength, dosage form as inhalation solution, and an illustration of the unit-dose vial. The package indicates a carton containing one pouch with 25 x 3 mL vials, intended for respiratory inhalation use.*

FDA Label Image

0 63 mg Carton Cards

The image shows a flattened packaging label for Albuterol Sulfate Inhalation Solution, 0.63 mg/3 mL strength, from Ritedose Pharmaceuticals, LLC. It includes branding, dosage strength highlighted in orange, and an illustration of a unit-dose vial. The label states it is for inhalation use only and contains 5 pouches of 5 unit-dose vials each.*

FDA Label Image

0 63 mg Carton Singles

Box packaging label for Albuterol Sulfate Inhalation Solution 0.63 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label displays the drug name, strength, dosage form (solution for inhalation), and indicates it contains sterile unit-dose vials. The package holds 30 pouches of 1 x 3 mL vial each. Barcodes and additional usage and storage instructions appear on the label.*

FDA Label Image

1 25 mg Carton Brick

Packaging label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label indicates the product is a respiratory inhalation solution supplied in sterile unit-dose vials, with each carton containing one pouch of 25 x 3 mL vials. The label includes dosage strength, NDC 76204-011-25, barcodes, and ingredients.*

FDA Label Image

1 25 mg Carton Cards

Packaging label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL by Ritedose Pharmaceuticals, LLC. The carton contains 5 pouches of 3 mL sterile unit-dose vials for inhalation. The label features dosage, barcodes, product name, and manufacturer details in a mostly white design with blue accent panels.*

FDA Label Image

1 25 mg Carton Singles

Packaging label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL by Ritedose Pharmaceuticals, LLC. The label states this is a solution for respiratory inhalation, containing 1.25 mg of albuterol sulfate per 3 mL vial. It indicates sterile unit-dose vials in the carton. Barcodes and NDC number 76204-011-01 are visible on the label.*

FDA Label Image

Image-01 (Image 01)

Chemical structure of Albuterol Sulfate showing the molecular components and arrangement including phenol groups, hydroxyl groups, a side chain with an isopropyl group, and sulfate ions.*

FDA Label Image

Image-02 (Image 02)

A line graph showing percent change over time from pre-dose up to 6 hours, comparing treatments with Albuterol Sulfate Inhalation Solution at 1.25 mg, 0.63 mg, and placebo. The y-axis represents percent change, and the x-axis represents hours from pre-dose. The graph presents data for three groups indicated in the legend: albuterol 1.25 mg, albuterol 0.63 mg, and placebo.*

FDA Label Image

Image-03 (Image 03)

A line graph depicting percent change over time in hours from pre-dose for three treatments: albuterol 1.25 mg, albuterol 0.63 mg, and placebo. The x-axis represents hours from pre-dose (0 to 6 hours), and the y-axis represents percent change. Three distinct lines correspond to each treatment, showing their respective percent changes over time.*

FDA Label Image

Image-04 (Image 04)

An instructional diagram showing a hand using a dropper to dispense liquid into a device, likely an inhalation medication chamber or nebulizer component, demonstrating the preparation step for Albuterol Sulfate Inhalation Solution.*

FDA Label Image

Image-05 (Image 05)

An instructional diagram showing a hand holding an Albuterol Sulfate Inhalation Solution inhaler with the mouthpiece removed, and another hand holding the mouthpiece cap, demonstrating the assembly or cleaning process for the inhaler device.*

FDA Label Image

Image-06 (Image 06)

Instructional illustrations showing a person using an inhalation device with a mouthpiece for Albuterol Sulfate Inhalation Solution. Figure 3 depicts the person inhaling through the mouthpiece, while Figure 4 shows the use of a spacer or holding chamber device during inhalation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.